Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia

Sebastian R. Hobson, Rutu Acharya, Rebecca Lim, Siow Teng Chan, Joanne Mockler, Euan M. Wallace

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Circulating markers for endothelial activation such as endothelin-1 (ET-1), ICAM-1 and VCAM-1 are elevated in women with preeclampsia. Using human umbilical vein endothelial cells (HUVECs) as an in vitro model of the maternal vasculature, we show that activin A and preeclamptic serum upregulate ET-1, ICAM-1, and VCAM-1 in HUVECs. Further, we show that follistatin, a specific binding protein for activin, mitigates the upregulation of ET-1, ICAM-1 and VCAM-1 in HUVECs exposed to either activin A or preeclamptic serum. These data are consistent with activin A contributing to the pathophysiology of preeclampsia and suggest that therapies targeting activin signalling are worth exploring.
Original languageEnglish
Pages (from-to)130-133
Number of pages4
JournalPregnancy Hypertension
Volume6
Issue number2
DOIs
Publication statusPublished - Apr 2016

Keywords

  • Preeclampsia
  • Activin
  • Follistatin
  • Endothelin
  • ICAM
  • VCAM

Cite this

Hobson, Sebastian R. ; Acharya, Rutu ; Lim, Rebecca ; Chan, Siow Teng ; Mockler, Joanne ; Wallace, Euan M. / Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia. In: Pregnancy Hypertension. 2016 ; Vol. 6, No. 2. pp. 130-133.
@article{b04fa03c7a8a4ddda5fa65831774563b,
title = "Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia",
abstract = "Circulating markers for endothelial activation such as endothelin-1 (ET-1), ICAM-1 and VCAM-1 are elevated in women with preeclampsia. Using human umbilical vein endothelial cells (HUVECs) as an in vitro model of the maternal vasculature, we show that activin A and preeclamptic serum upregulate ET-1, ICAM-1, and VCAM-1 in HUVECs. Further, we show that follistatin, a specific binding protein for activin, mitigates the upregulation of ET-1, ICAM-1 and VCAM-1 in HUVECs exposed to either activin A or preeclamptic serum. These data are consistent with activin A contributing to the pathophysiology of preeclampsia and suggest that therapies targeting activin signalling are worth exploring.",
keywords = "Preeclampsia, Activin, Follistatin, Endothelin, ICAM, VCAM",
author = "Hobson, {Sebastian R.} and Rutu Acharya and Rebecca Lim and Chan, {Siow Teng} and Joanne Mockler and Wallace, {Euan M.}",
year = "2016",
month = "4",
doi = "10.1016/j.preghy.2016.03.001",
language = "English",
volume = "6",
pages = "130--133",
journal = "Pregnancy Hypertension",
issn = "2210-7789",
publisher = "Elsevier",
number = "2",

}

Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia. / Hobson, Sebastian R.; Acharya, Rutu; Lim, Rebecca; Chan, Siow Teng; Mockler, Joanne; Wallace, Euan M.

In: Pregnancy Hypertension, Vol. 6, No. 2, 04.2016, p. 130-133.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia

AU - Hobson, Sebastian R.

AU - Acharya, Rutu

AU - Lim, Rebecca

AU - Chan, Siow Teng

AU - Mockler, Joanne

AU - Wallace, Euan M.

PY - 2016/4

Y1 - 2016/4

N2 - Circulating markers for endothelial activation such as endothelin-1 (ET-1), ICAM-1 and VCAM-1 are elevated in women with preeclampsia. Using human umbilical vein endothelial cells (HUVECs) as an in vitro model of the maternal vasculature, we show that activin A and preeclamptic serum upregulate ET-1, ICAM-1, and VCAM-1 in HUVECs. Further, we show that follistatin, a specific binding protein for activin, mitigates the upregulation of ET-1, ICAM-1 and VCAM-1 in HUVECs exposed to either activin A or preeclamptic serum. These data are consistent with activin A contributing to the pathophysiology of preeclampsia and suggest that therapies targeting activin signalling are worth exploring.

AB - Circulating markers for endothelial activation such as endothelin-1 (ET-1), ICAM-1 and VCAM-1 are elevated in women with preeclampsia. Using human umbilical vein endothelial cells (HUVECs) as an in vitro model of the maternal vasculature, we show that activin A and preeclamptic serum upregulate ET-1, ICAM-1, and VCAM-1 in HUVECs. Further, we show that follistatin, a specific binding protein for activin, mitigates the upregulation of ET-1, ICAM-1 and VCAM-1 in HUVECs exposed to either activin A or preeclamptic serum. These data are consistent with activin A contributing to the pathophysiology of preeclampsia and suggest that therapies targeting activin signalling are worth exploring.

KW - Preeclampsia

KW - Activin

KW - Follistatin

KW - Endothelin

KW - ICAM

KW - VCAM

UR - http://www.sciencedirect.com.ezproxy.lib.monash.edu.au/science/article/pii/S2210778915300453

UR - https://www-scopus-com.ezproxy.lib.monash.edu.au/record/display.uri?eid=2-s2.0-84962376231&origin=resultslist&sort=plf-f&src=s&st1=10.1016%2fj.preghy.2016.03.001&st2=&sid=3CB60C2F56E4D2877DB6683A4947769E.wsnAw8kcdt7IPYLO0V48gA%3a10&sot=b&sdt=b&sl=33&s=DOI%2810.1016%2fj.preghy.2016.03.001%29&relpos=0&citeCnt=1&searchTerm=

U2 - 10.1016/j.preghy.2016.03.001

DO - 10.1016/j.preghy.2016.03.001

M3 - Article

VL - 6

SP - 130

EP - 133

JO - Pregnancy Hypertension

JF - Pregnancy Hypertension

SN - 2210-7789

IS - 2

ER -